Calcium and Vitamin D Help Bone Mass in Older Women
Calcium and vitamin D supplements in healthy postmenopausal women provide a modest benefit in preserving bone mass and prevent hip fractures in certain groups including older women according, to a report in the New England Journal of Medicine.
The supplements do not prevent other types of fractures or colorectal cancer, researchers say. While generally well tolerated, the supplements were associated with an increased risk of kidney stones.
Osteoporosis, a skeletal disorder characterized by weakened bones leading to an increased risk of fracture, is a major cause of disability, loss of independence, and death.
It contributes to an estimated 300,000 hip fractures in the US each year. Four out of 10 women over age 50 will experience a fracture of the hip, spine, or wrist in their lifetime.
Ten million people in the US are estimated to have osteoporosis and 34 million more have low bone mass, placing them at greater risk for fracture.
The findings were taken from the Women’s Health Initiative (WHI), sponsored by the National Heart, Lung, and Blood Institute (NHLBI).
“This important study provides guidance for women on the risks and benefits of supplementing their diets with calcium and vitamin D,” says Dr. Elizabeth G. Nabel, NHLBI director and director of the Women’s Health Initiative.
The overall results suggest that women, particularly those over 60, should consider taking calcium and vitamin D for bone health but they should not expect these supplements to help prevent colorectal cancer.
The WHI Calcium with Vitamin D (CaD) trial of 36,282 postmenopausal women ages 50 to 79 found a small but significant 1 percent higher hip bone density for those taking calcium combined with vitamin D compared to those taking placebo.
During the trial, 374 women had hip fractures with a fracture rate of 14 per 10,000 cases per year in the supplemented group compared to 16 per 10,000 per year in the placebo group.
This 12 percent reduction in hip fracture in those taking the calcium plus vitamin D supplement was not statistically significant. However, women who consistently took the full supplement dose experienced a significant 29 percent decrease in hip fracture.
Women older than age 60 had a significant 21 percent reduction in hip fracture. The supplements had no significant effect on spine or total fractures.
Calcium/vitamin D supplements provided no detectable effect on the incidence of colorectal cancer. There were similar rates of cancer in both the calcium/vitamin D and placebo (non-active substance) groups (13 cases per 10,000/year compared to 12 cases per 10,000/year respectively).
Overall, the supplements were well tolerated by participants and the only adverse effect found was a 17 percent increase in kidney stones. Kidney stones were reported by 449 women (34 cases per 10,000 per year) in the CaD group compared to 381 women (29 cases per 10,000 per year) in the placebo group.
The WHI Calcium with Vitamin D trial was primarily designed to study the effect of calcium/vitamin D supplementation on preventing hip fracture with secondary study objectives testing the effect of CaD on spine and other types of fracture and on colorectal cancer.
Half of the over 36,000 participants in the CaD trial received a daily dose of 1000 milligrams of calcium carbonate combined with 400 international units (IUs) of vitamin D3. The other half of the study group received placebo pills in similarly marked bottles. Participants could choose between chewable pills or ones that could be swallowed.
During the study, a sub-set of participants had regular bone density scans. Study participants were followed for an average of seven years with three-quarters of them still taking their pills by the end of the study.
“Given the serious public health burden of fractures associated with osteoporosis, it is important to learn as much as possible about ways to prevent and treat bone loss,” says Dr. Joan McGowan, of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and a co-author on the paper.
According to the study’s authors, there are several possible reasons why despite improvements in hip bone density, the reduction in hip fractures was smaller than expected and only statistically significant in certain groups - those over 60 and women who took the full intended dose of combined supplements.
”Although 76 percent of women were still taking study pills at the end of the trial, only 59 percent were taking the intended number of pills,” notes Dr. Rebecca D. Jackson, endocrinologist and the study’s lead investigator at Ohio State University in Columbus.
"The low rates could be due to a number of factors, such as the high body mass index of participants (heavier people have stronger bones), the inclusion of relatively few women over age 70 years, and the fact that many participants were already using calcium and vitamin D supplements, or were on hormone therapy,” she says.
Dr. McGowan explains, “If we look at all the findings together, for every 10,000 women treated for one year, two hip fractures would be prevented and five cases of kidney stones would be caused. The number of hip fractures prevented would climb to four for compliant patients and six for women over 60.
“Since hip fractures are considered to be more serious than kidney stones, on balance, the public health benefit of the supplements outweighs the risks,” she says.
“The study’s findings of slowed bone loss and the reduction in hip fractures for some groups suggest a role for these supplements in preventing hip fracture in generally healthy postmenopausal women and support the current Surgeon General’s recommendations for these nutrients,” adds Dr. McGowan, who is also the senior scientific editor of the Surgeon General ’s report on bone health.
She notes, however, that supplements may not be necessary for healthy women whose diet meets recommended levels of calcium and vitamin D.
The study found no evidence of benefit from calcium/vitamin D for the prevention of colorectal cancer, according to Dr. Jean Wactawski-Wende, epidemiologist and the study’s lead investigator at the University at Buffalo.
Over an average of seven years, 322 women in the study were diagnosed with invasive colorectal cancer. There was no statistically significant difference between the two groups in number of cancer cases or in the characteristics or severity of tumors.
There were also no differences between groups in the number of polyps reported by the participants. When the investigators analyzed only the data obtained from participants who were taking most of their study pills, there was still no benefit seen from calcium/vitamin D supplementation.
“As the third leading cause of cancer death and incidence for women in the United States, there is great interest in the prevention of colorectal cancer. Unfortunately, our findings do not validate some previous studies and polyp prevention trials which showed a benefit for calcium/vitamin D,” says Dr. Wactawski-Wende.
She adds, however, that study design and population issues may have limited the study’s ability to show a protective effect of calcium/vitamin D.
Since participants were not restricted from taking personal calcium or vitamin D supplements, they had a relatively high calcium and vitamin D intake at enrollment and intake rose even higher during the trial so the impact of study supplementation may have been muted.
Duration may have also been a factor, notes Dr. Wactawski-Wende. “If the benefit of CaD is for prevention of cancer at its early stages and colorectal cancer takes 10 to 20 years to develop, seven years of supplementation and follow-up may not be enough time to show a benefit.
“Still, we found no trend toward protection in the later years of follow-up,” she remarks. She adds that the ongoing five-year WHI extension study will continue to track occurrences of colorectal cancer - as well as other diseases - and may provide answers on later effects of the WHI CaD supplementation.
Always consult your physician for more information.
|
Osteoporosis, or porous bone, is a disease in which there is a loss of bone mass and destruction of bone tissue. This process causes weakening of the bones and makes them more likely to break.
The bones most often affected are the hips, spine, and wrists.
Some women are at greater risk for osteoporosis - the decrease of bone mass and density as a result of the depletion of bone calcium and protein - than others.
Your physician can help you determine your risk of developing osteoporosis by taking your personal and family medical history, and by performing a bone density test or bone mass measurement.
A bone density test, also known as bone mass measurement or bone mineral density test, measures the strength and density of your bones as you approach menopause and, when the test is repeated sometime later, can help determine how quickly you are losing bone mass and density.
These tests are painless, noninvasive, and safe. They compare your bone density with standards for what is expected in someone of your age, gender, and size and to the optimal peak bone density of a healthy young adult of the same gender.
Bone density testing can help to:
-
detect low bone density before a fracture occurs
-
confirm a diagnosis of osteoporosis if you have already fractured
-
predict your chances of fracturing in the future
-
determine your rate of bone loss and/or monitor the effects of treatment if the test is conducted at intervals of a year or more
If you have one or more of the following risk factors for osteoporosis, you may want to consider having a bone density test:
-
You have already experienced a bone fracture that may be the result of thinning bones.
-
Your mother, grandmother, or another close relative had osteoporosis or bone fractures.
-
Over a long period of time, you have taken medication that accelerates bone loss, such as corticosteroids for treating rheumatoid arthritis or other conditions, or some anti-seizure medications.
-
You have low body weight, a slight build, or a light complexion.
-
You have a history of cigarette smoking or heavy drinking.
Persons with osteoporosis may not develop any symptoms, or may have pain in their bones and muscles, particularly in their back. The symptoms of osteoporosis may resemble other bone disorders or medical problems.
Always consult your physician for more information.
|
